quinazolines has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Hu, R; Jiang, H; Sun, Y; Yan, J; Yang, Y | 1 |
| Jiang, J; Li, K; Wu, X; Yao, P; Zhang, J | 1 |
2 other study(ies) available for quinazolines and Carcinoma 256, Walker
| Article | Year |
|---|---|
Activation of the spinal EGFR signaling pathway in a rat model of cancer-induced bone pain with morphine tolerance.
Topics: Analgesics, Opioid; Animals; Bone Neoplasms; Cancer Pain; Carcinoma 256, Walker; Drug Tolerance; Enzyme Inhibitors; ErbB Receptors; MAP Kinase Signaling System; Microglia; Morphine; Phosphorylation; Quinazolines; Rats; Spinal Cord; Tibia; Tyrphostins | 2021 |
Activation of spinal neuregulin 1-ErbB2 signaling pathway in a rat model of cancer-induced bone pain.
Topics: Animals; Carcinoma 256, Walker; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Neoplasm Transplantation; Neoplasms; Neuregulin-1; Pain; Quinazolines; Rats; Receptor, ErbB-2; Signal Transduction; Tibia | 2014 |